z-logo
open-access-imgOpen Access
Bacteriological Profile and Antibiogram of Uropathogens in Pediatric Age Group Population from a Tertiary Care Hospital in Western Nepal
Author(s) -
Subhash Lal Karn,
Ravi Kumar Kushwaha,
Sulochana Khatiwada,
Santosh Adhikari,
Buddhi Raj Pokhrel,
Binaya Tamang,
Raju Kafle
Publication year - 2020
Publication title -
journal of universal college of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2350-8582
pISSN - 2091-2846
DOI - 10.3126/jucms.v8i02.34287
Subject(s) - medicine , urine , antibiogram , bacteriuria , urinary system , pediatrics , imipenem , antibiotics , antibiotic resistance , microbiology and biotechnology , biology
Urinary tract infection (UTI) is one of the most common bacterial infections encountered in day to day pediatrics practices. It has been a significant cause of acute morbidity and is also a significant cause of hospital attendance among children. In children, despite the presence of simple and reliable methods of preliminary screening of children's urine, UTI continues to be under-diagnosed. AIMS & OBJECTIVE The study aimed to know the clinical and bacteriological profile of urinary tract infection and to find out the drug resistance of bacterial isolates in pediatric age group population attending Universal College of Medical Sciences Teaching Hospital, Bhairahawa. MATERIALS & METHODOLOGY Three hundred and seven non-repetitive urine samples from UTI suspected pediatric patients were included in the study and subjected for microscopic urine analysis followed by semi- quantitative culture by calibrated loop method for estimation of significant bacteriuria. RESULTS Present study showed that UTIs are more common in girls (54.07%) than in boys (45.92%). In terms of urine culture, 98 (31.92%) subjects had positive urine culture. There was no consistent symptom common to all patients with UTI other than fever. E. coli was the commonest uropathogens isolated. E. coli was the principal isolates showing high susceptibility to Imipenem (90.5%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here